Neovastat Completed Phase 3 Trials for Renal Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00005995AE-941 in Treating Patients With Metastatic Kidney Cancer